Skip to content
Log in
Sponsored AI Networking Cookbook: Practical recipes for AI-assisted network automation and development AI Networking Cookbook: Practical recipes for AI-assisted network automation and development

Integrative analysis of TCGA data identifies hsa-miR-200a as a breast cancer-associated microRNA biomarker with exploratory serum validation.

Kwangmin Park Eun You Kim Eun Ju Lee Heeju Nam Hye-Won Park Eun Hye Lee Hyun-Jeong Kim K. Lee D. Jeon Jungho Kim
Aug 2026 · Genes & Genomics · 0 citations · 29 references
Medicine

TL;DR

Findings support hsa-miR-200a as a potential breast cancer-associated miRNA biomarker candidate and highlight the utility of integrative transcriptomic and exploratory clinical serum approaches for future precision diagnostics.

DOI PubMed Semantic Scholar
View source

Similar papers

Sep 2026

Identification of a circulating miR-6838-5p/miR-195-5p signature in invasive ductal breast carcinoma

The miR-6838-5p/miR-195-5p combination represents a promising circulating miRNA signature for invasive ductal breast carcinoma and its consistent discriminatory performance in the discovery cohort and an independent serum cohort supports further evaluation in larger prospective studies.

Mustafa Barış Zeytunlu, Fazilet Esra Incedere Duzdag, Hüseyin Esin et al. · 0 citations
Open access Sep 2026

Plasma miR-141-3p as a Potential Diagnostic Biomarker for Early Breast Cancer and a Functional Regulator with Tumor-Suppressive Effects in Luminal A Breast Cancer Cells.

Circulating miR-141-3p shows promise as a non-invasive biomarker for BC detection and risk discrimination, although its specificity as a stand-alone marker may be limited.

T. T. Duong, Thanh Thi Ngoc Nguyen, L. H. Huynh et al. · 0 citations
Open access Aug 2026

miR-451a is a differentially expressed blood-based microRNA in newly diagnosed CML identified by high-throughput profiling

microRNAs (miRNAs) are emerging as promising biomarkers in hematological malignancies due to their stability in blood. This study aimed to investigate the differential expression of miRNAs in chronic myeloid leukemia (CML) and evaluate the potential of miR-451a as a candidate whole-blood miRNA marker. We c...

Surbhi Gupta, Nitu Nigam, Abdullah H. Maad et al. · 0 citations
Open access Aug 2026

A circulating three-miRNA panel (hsa-miR-29b-3p, hsa-miR-19b-3p, hsa-miR-30e-5p) for early-stage ovarian cancer detection: a machine-learning bioinformatics approach

Background Ovarian cancer (OVCA) remains one of the most lethal gynecological malignancies, primarily due to late-stage diagnosis and the lack of reliable early-detection biomarkers. Circulating microRNAs (miRNAs) have emerged as promising non-invasive biomarkers for cancer detection and prognosis. Objective This study...

Ahmed El Hosseiny, Meriem Yagoubi, Ahmed Moustafa et al. · 0 citations
Open access Aug 2026

Differential Serum MicroRNA Profiling in Benign and Malignant Ovarian Tumours: An Exploratory Study Identifying hsa-miR-200c-3p as a Candidate Diagnostic Biomarker

Background/Objectives: Preoperative discrimination of benign from malignant adnexal masses remains a major clinical challenge, and circulating microRNAs (miRNAs) are candidate non-invasive biomarkers. This exploratory, hypothesis-generating study—not a diagnostic validation study—evaluated serum hsa-miR-200c-3p as a ca...

J. D. Santotoribio, Juan Corral-Pérez, Laura Ávila-Cabeza-de-Vaca et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.